Citadel Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127M Buy
1,468,300
+386,200
+36% +$37M 0.02% 666
2025
Q4
$104M Buy
1,082,100
+230,900
+27% +$22.4M 0.02% 841
2025
Q3
$81.1M Sell
851,200
-469,600
-36% -$43.2M 0.01% 998
2025
Q2
$115M Sell
1,320,800
-673,300
-34% -$57.1M 0.02% 682
2025
Q1
$179M Buy
1,994,100
+832,600
+72% +$74.5M 0.03% 407
2024
Q4
$92.8M Sell
1,161,500
-240,400
-17% -$20.8M 0.02% 780
2024
Q3
$126M Sell
1,401,900
-50,700
-3% -$4.27M 0.02% 564
2024
Q2
$114M Buy
1,452,600
+403,700
+38% +$33.1M 0.02% 612
2024
Q1
$91.4M Sell
1,048,900
-623,400
-37% -$53.2M 0.02% 756
2023
Q4
$138M Buy
1,672,300
+75,100
+5% +$5.72M 0.03% 508
2023
Q3
$125M Buy
1,597,200
+108,000
+7% +$9.04M 0.03% 513
2023
Q2
$131M Sell
1,489,200
-814,200
-35% -$70.1M 0.03% 478
2023
Q1
$186M Sell
2,303,400
-151,900
-6% -$12.4M 0.04% 351
2022
Q4
$191M Buy
2,455,300
+262,100
+12% +$21.2M 0.04% 347
2022
Q3
$177M Buy
2,193,200
+258,200
+13% +$23.2M 0.04% 356
2022
Q2
$174M Buy
1,935,000
+312,400
+19% +$31.7M 0.04% 326
2022
Q1
$180M Buy
1,622,600
+744,800
+85% +$78.7M 0.04% 390
2021
Q4
$90.8M Sell
877,800
-33,600
-4% -$3.89M 0.02% 727
2021
Q3
$114M Buy
911,400
+256,000
+39% +$33.1M 0.02% 593
2021
Q2
$81.4M Buy
655,400
+148,000
+29% +$18.6M 0.02% 794
2021
Q1
$59.9M Buy
507,400
+25,200
+5% +$2.95M 0.01% 902
2020
Q4
$56.5M Sell
482,200
-405,800
-46% -$44.7M 0.01% 862
2020
Q3
$92.3M Buy
888,000
+46,800
+6% +$4.7M 0.03% 504
2020
Q2
$77.1M Buy
841,200
+128,400
+18% +$12.3M 0.03% 537
2020
Q1
$64.3M Buy
712,800
+536,700
+305% +$57.1M 0.03% 529
2019
Q4
$20M Sell
176,100
-320,000
-65% -$35.1M 0.01% 1482
2019
Q3
$53.9M Sell
496,100
-255,500
-34% -$26.7M 0.03% 711
2019
Q2
$73.2M Buy
751,600
+284,600
+61% +$26M 0.03% 534
2019
Q1
$42.5M Sell
467,000
-410,500
-47% -$36.7M 0.02% 783
2018
Q4
$79.8M Buy
877,500
+94,700
+12% +$8.85M 0.04% 408
2018
Q3
$77M Buy
782,800
+181,300
+30% +$16.8M 0.03% 529
2018
Q2
$51.5M Buy
601,500
+261,700
+77% +$21.9M 0.03% 685
2018
Q1
$27.3M Buy
339,800
+228,700
+206% +$18.9M 0.01% 905
2017
Q4
$8.97M Sell
111,100
-79,800
-42% -$6.39M 0.01% 1838
2017
Q3
$14.8M Sell
190,900
-62,300
-25% -$5.17M 0.01% 1277
2017
Q2
$22.5M Sell
253,200
-103,200
-29% -$8.7M 0.02% 930
2017
Q1
$28.7M Buy
356,400
+58,100
+19% +$4.54M 0.03% 742
2016
Q4
$21.2M Buy
298,300
+40,500
+16% +$3.18M 0.02% 838
2016
Q3
$22.3M Sell
257,800
-323,300
-56% -$28.2M 0.02% 809
2016
Q2
$50.4M Buy
581,100
+338,500
+140% +$27.4M 0.06% 335
2016
Q1
$18.2M Buy
242,600
+8,700
+4% +$655K 0.02% 806
2015
Q4
$18M Sell
233,900
-47,100
-17% -$3.55M 0.02% 896
2015
Q3
$18.8M Buy
281,000
+46,700
+20% +$3.44M 0.02% 951
2015
Q2
$17.4M Buy
234,300
+35,500
+18% +$2.71M 0.02% 1092
2015
Q1
$15.5M Buy
198,800
+36,100
+22% +$2.74M 0.01% 1139
2014
Q4
$11.7M Sell
162,700
-107,700
-40% -$7.48M 0.01% 1294
2014
Q3
$16.8M Buy
270,400
+116,900
+76% +$7.43M 0.02% 1012
2014
Q2
$9.79M Sell
153,500
-6,700
-4% -$407K 0.01% 1285
2014
Q1
$9.86M Sell
160,200
-31,200
-16% -$1.82M 0.01% 1275
2013
Q4
$11M Buy
191,400
+70,100
+58% +$3.97M 0.01% 1153
2013
Q3
$6.46M Sell
121,300
-84,000
-41% -$4.52M 0.01% 1392
2013
Q2
$10.6M Buy
+205,300
New +$10.1M 0.02% 1033

Other funds holding MDT

Citadel Advisors's MDT Position: Q1 2026 in Review

Citadel Advisors reduced its Medtronic (MDT) stake by 81% in Q1 2026, selling an estimated $407M and leaving 982,741 shares worth $85.2M. The position accounts for 0.01% of the portfolio, ranked #921.

Citadel Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $854M in Q2 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Citadel Advisors held 982,741 shares of Medtronic worth $85.2M as of Q1 2026.
  • Citadel Advisors sold 4,246,447 Medtronic shares in Q1 2026, an estimated $407M.
  • Medtronic made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #921 holding.
  • Citadel Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Medtronic position peaked at $854M in Q2 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.